Prescription drug · ANDA
Heparin Sodium NDC 63739-900
Heparin sodium 1000 [USP'U]/mL · Injection, Solution · Intravenous, Subcutaneous · McKesson Corporation dba SKY Packaging
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Heparin Sodium
- Generic name (nonproprietary)
- heparin sodium
- Active ingredients
- Heparin sodium — 1000 [USP'U]/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202732
- Marketing start
- Listing expires
- Other FDA classes
- Heparin (Chemical structure)
- Identifiers
- Product ID 63739-900_2c31ae6a-f9c6-fb65-e063-6294a90af0e1SPL ID 2c31ae6a-f9c6-fb65-e063-6294a90af0e1SPL set ID 7f05762a-7527-4796-b21e-68277aec379eRxCUI 1361226, 1361574, 1361615, 1362831, 1658647UNII ZZ45AB24CAUPC 0363739986251, 0363739975279, 0363739964259, 0363739942158, 0363739953253, 0363739900264, 0363739920255
- Pharmacologic class
- Anti-coagulant; Unfractionated Heparin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Heparin sodium injection is indicated for: Prophylaxis and treatment of venous thrombosis and pulmonary embolism; Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; Atrial fibrillation with embolization; Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); Prevention of clotting in arterial and cardiac surgery; Prophylaxis and treatment of peripheral arterial embolism. Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. Heparin sodium injection is an an…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202732
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Hepalink USA Inc. | 81952-115 |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Sandoz Inc. | 0781-3555 |